Delivery Order SPE2DB20D3303-SPE2DB24FA1LC

Award Date 7/25/24
Potential Completion Date 8/15/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S to the Defense Logistics Agency (DLA). The $25,920.62 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $77,761.80, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. It is a firm fixed-price delivery order contract with an ultimate completion date of August 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $58,042.02 and an ultimate completion date of December 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award to Amerisourcebergen Drug Corp is a $26,816.48 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA). The contract provides the DLA with 4566789792 units of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
The Defense Logistics Agency (DLA) awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The $12,960.30 firm fixed price delivery order has an ultimate completion date of October 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of the drug VYNDAMAX 61 MG CAPSULE UD 30S, with a ceiling value of $25,920.62 and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a medication, with a ceiling value of $26,816.48. The contract is a firm fixed price delivery order that runs through February 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $25,920.62, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1LC
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,920.62 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and was awarded on July 25, 2024, with an ultimate completion date of August 15, 2024.

Generated 10/27/24, 2:55 AM